Hidden in Plain Sight: Alphavirus Persistence and Its Potential for Driving Chronic Pathogenesis
Alphaviruses have historically been viewed as acute, self-limiting pathogens. However, growing evidence shows that viral RNA and antigens can persist in vertebrate hosts long after the resolution of acute infection, a phenomenon known as viral persistence. Viral persistence reflects a dynamic interplay between viral replication-including shifts from lytic to non-lytic infection-and host defenses, which together establish cellular and tissue niches that enable evasion of immune-mediated clearance. Within vertebrate hosts, alphaviruses exhibit broad tissue tropism, infecting diverse cell types that may differentially support long-term persistence. Emerging evidence suggests that viral persistence arises through three interconnected processes: (i) selective infection of specific cellular niches, (ii) reprogramming of host cellular pathways, and (iii) modulation of immune responses. Yet, the extent to which viral or host determinants shape this balance, and how persistence contributes to chronic disease, remains unresolved. Here, we synthesize current <i>in vitro</i> and <i>in vivo</i> evidence of alphavirus persistence in vertebrate hosts and discuss potential mechanisms by which alphaviruses establish and maintain persistent infection beyond the acute phase. We further underscore critical gaps in current knowledge and outline future research avenues essential for elucidating the mechanisms underlying alphavirus pathogenesis.
Authors
- María G. Noval (ORCID: https://orcid.org/0000-0002-9140-0565)
- Zhenlan Yao (ORCID: https://orcid.org/0000-0001-6588-0633)
- Maria del Mar Villanueva Guzman
- Melody M. H. Li
Institutions
- University of California, Los Angeles (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Viruses
- Published
- 2025-12-24
- DOI
- https://doi.org/10.3390/v18010030
- Citations
- 1
- Primary Topic
- Viral Infections and Outbreaks Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- W. M. Keck Foundation
- National Institutes of Health
- University of California, Los Angeles
- David Geffen School of Medicine, University of California, Los Angeles